Soldier did not harm himself before death in Catterick
A soldier whose dead body lay undiscovered for three weeks in his bed at an Army barracks had not harmed himself before he died, an inquest has heard.On the first day of the inquest into the death of 33-year-old L/Cpl Bernard Mongan at Catterick Barracks in January 2020, North Yorkshire Coroners' Court heard that the soldier had not been seen since Christmas.Opening the inquest, senior coroner Jon Heath considered whether the soldier could have died from poisoning after barbiturates including Promethezene and Phenobarbital, which have a sedating effect, were found in his system.But paramedic Paul Spence told the court there was "no evidence of self-harm or suicide".
Mr Spence, from Yorkshire Ambulance Service, said: "He was found by friends in his bed and had not been seen at work since Christmas time."There were no empty medication bottles nearby or signs of self-harm and had severe stages of decomposition, which made it harder to work out his death."
Also giving evidence, pathologist Dr Nigel Cooper said the state in which L/Cpl Mongan's body was found on 23 January 2020 meant it was difficult to determine how he had died."The levels of the two drugs can't kill him alone and would require a third substance," he told the court."There was an empty Jack Daniel's whiskey bottle found in his room...but no evidence of when or how quickly the alcohol was consumed.""I've thought about this, and I just don't have enough evidence to pull you in one way or another," Dr Cooper explained.He added that there had been nothing such as problems with L/Cpl Mongan's heart or brain to explain his sudden death, and no injuries had been found on his body."If he had taken the alcohol and drugs he could have died, but I just don't know if he did," Dr Cooper added.
'Amazing dad'
The inquest into the death of L/Cpl Mongan also heard from the soldier's mother, Mary Mongan, who called her son a "dedicated father of three".Ms Mongan told the court: "Family meant everything to him and he meant everything to us."Even though he has gone, we are still proud of all his achievement, as we had a very close bond."It's devastating for all of us that he is no longer with us. His death has left us with so many questions as it came as such a shock for us all."Meanwhile, L/Cpl Mongan's wife, Beth Mongan, who was separated from him at the time of his death, said the 33-year-old "had a wicked sense of humour".He was "an absolutely amazing dad" and was "loving and ambitious" for his three children, she said."He would read them bedtime stories every night and left them with a love of reading, too."Even though we were separated, we still spent a lot of time together. He was a sweetheart."The inquest, which is expected to last three weeks, continues.
Listen to highlights from North Yorkshire on BBC Sounds, catch up with the latest episode of Look North.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
13 minutes ago
- The Independent
Weight loss pill shows promise in new trial
A new weight loss medication, which can be offered by injection or tablet, can help patients lose a significant amount weight, studies suggest. An early study have found that people who received higher doses of amycretin as a weekly jab lost 24.3% of their body weight after 36 weeks of treatment. And initial trials assessing a tablet form of the drug also showed promising results, with patients taking daily tablets losing an average of 13.1% of their body weight after 12 weeks. Weight loss jabs have been hailed as transformative by NHS leaders. But injections come with additional work for over-stretched health services so tablet forms of medication may offer a new hope for the millions of people looking to lose weight. It has been estimated that around 1.5 million Britons are having weight loss jabs, which have been either prescribed through specialist weight loss services or private prescriptions. GPs will be able to dish out that jabs from next week. Amycretin, made by Novo Nordisk, helps to control blood sugar and appetite by targeting two specific receptors in the body – GLP-1 and the amylin receptor. An early trial in 125 adults testing weekly injections of amycretin, which has been published in The Lancet, found that those taking the highest dosage (60mg) lost 24.3% after 36 weeks of treatment. It also showed signs in improving blood sugar levels. Side effects included nausea and vomiting and were mostly mild to moderate and resolved by the end of treatment. 'These phase 1b/2a data support the potential of once-weekly subcutaneous amycretin as a therapeutic for people living with overweight or obesity,' the authors wrote. 'Amycretin appeared safe and tolerable, and there were significant reductions in body weight after 36 weeks of treatment.' The second early trial, published in the same journal, assessed amycretin in tablet form in 144 people over 12 weeks. There were mild to moderate side effects including loss of appetite, nausea and vomiting. Researchers found that people taking the highest dose of 100mg per day, lost 13.1% of their body weight over four months. The authors wrote: 'Amycretin effectively lowered body weight and improved metabolic and glycaemic parameters in people with overweight or obesity. 'Longer studies with more participants are warranted for evaluation of the safety and efficacy of amycretin in individuals living with obesity and type 2 diabetes, and to optimise the dosing regimen.' The studies were also presented at the American Diabetes Association's Scientific Sessions in Chicago, in the US. It comes as a separate study, which was published at the same meeting, examined the effects of weight loss jab Wegovy at higher doses. Researchers found that giving patients 7.2mg of Wegovy, also known as semaglutide, once a week led to an average weight loss of 20.7%, with a third of participants losing 25% or more of their body weight after 72 weeks.
Daily Mail
34 minutes ago
- Daily Mail
EXCLUSIVE Revealed: Kenneth Noye's new life. He brutally stabbed two men and stole £26m. Now as he swans around Kent with a much younger lover and plays doting grandfather, friends expose the dark truth
Life, of late, has been undeservedly kind to Kenneth Noye. Despite having a couple of killings under his belt, not to mention a ruthless hand in one of the most lucrative heists in British history, the gangster is a familiar sight on the streets of Sevenoaks, Kent. He is often seen pottering around his local supermarket, clutching an eco-friendly bag for life, nipping into the gym opposite his top-floor flat or simply whizzing around in his Mercedes 4x4. Noye, 78, has been spotted, too, playing the part of doting grandfather alongside other families during sports day at a nearby £30,000-a-year private school.
Daily Mail
34 minutes ago
- Daily Mail
Erectile dysfunction drug Viagra has surprise new health benefit, scientists find - offering new hope to 3million ageing Britons
A surprising new health benefit has emerged from the sex drug Viagra - which means three million ageing Britons can now also enjoy a harder skull. The little blue tablet was found to increase the production of vital bone cells, preventing back pain and fractures in old age. Sildenafil - also known as Viagra - can help human stem cells transform into osteoblasts which help the human skeleton regenerate as it is completely replaced roughly once every 10 years. As humans get older, they lose more bone than is built, increasing the risk of breaks or osteoporosis, which makes bones brittle and painful. Follow-up tests on mice by Peking University also suggested a prevention of bone loss. Dr Menglong Hu and Dr Likun Wu told MailOnline: 'Our findings offer new insights into the physiological effects of the medicine. 'Sildenafil enhanced stem cell osteogenic differentiation and inhibited bone loss — it may usefully treat osteoporosis.' Viagra was invented as a heart drug in the 1980s before being found to help with erectile dysfunction. Some studies suggest it may also help reduce the risk of dementia. However, the have been cautions over the years that the drug could have some negative side effects, in particular if taken too much. A large quantity of the drug could result in a painful, 'uncomfortably and disproportionately large erection' called a priapism which could go on for hours. Some experts also found regularly taking the common drug may raise the risk of three serious eye conditions. Common side effects may include headaches, hot flushes, nausea, indigestion, dizziness and a stuffy nose. Nearly half of men between the ages of 40 and 70 suffer from erectile dysfunction in the UK - this is more than 4.5 million people. Though, reports suggest Viagra is now even becoming increasingly popular with younger individuals in their 20s and 30s. Last year, it emerged Viagra may help prevent dementia by boosting blood flow in the brain. 'This is the first trial to show that sildenafil gets into the blood vessels in the brain in people with this condition, improving blood flow and how responsive these blood vessels are,'Dr Alastair Webb, a neurologist and study author at Oxford University said.
